Circulating microRNAs as potential biomarkers of infectious disease

Frontiers in Immunology

Volumn 8, Issue FEB, 2017, Pages

  Correia, Carolina N ^a   Nalpas, Nicolas C ^a,b   McLoughlin, Kirsten E ^a   Browne, John A ^a   Gordon, Stephen V ^a   MacHugh, David E ^a   Shaughnessy, Ronan G ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Biomarker; Diagnostic; Infection; MicroRNA; Plasma; Serum; Transcriptomics

Indexed keywords

CIRCULATING MICRORNA; HIGH DENSITY LIPOPROTEIN; MICRORNA; MICRORNA 106A; MICRORNA 10A; MICRORNA 122; MICRORNA 124; MICRORNA 125B; MICRORNA 133A; MICRORNA 146A; MICRORNA 15; MICRORNA 150; MICRORNA 16; MICRORNA 182; MICRORNA 193B; MICRORNA 194; MICRORNA 20A; MICRORNA 210; MICRORNA 223; MICRORNA 297; MICRORNA 342 5P; MICRORNA 4695; MICRORNA 483; MICRORNA 486; MICRORNA 497; MICRORNA 574; MICRORNA 92A; MICRORNA 99A; RNA BINDING PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

BIOGENESIS; BODY FLUID; CAENORHABDITIS ELEGANS; CELL COMMUNICATION; CHICKENPOX; GENE EXPRESSION REGULATION; HAND FOOT AND MOUTH DISEASE; HEPATITIS B; HEPATITIS C; HIGH THROUGHPUT SEQUENCING; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFLUENZA; LUNG GRANULOMA; NATURAL KILLER CELL; PERTUSSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA EXTRACTION; SEPSIS; TRANSCRIPTION REGULATION; TUBERCULOSIS;

EID: 85014368563     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00118     Document Type: Review

References (224)

1. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther (2001) 69:89-95. doi: 10.1067/mcp.2001.113989
2. Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS (2010) 5:463-6. doi:10.1097/COH.0b013e32833ed177
3. Etheridge A, Lee I, Hood L, Galas D, Wang K. Extracellular microRNA: a new source of biomarkers. Mutat Res (2011) 717:85-90. doi:10.1016/j.mrfmmm.2011.03.004
4. Nalejska E, Maczynska E, Lewandowska MA. Prognostic and predictive biomarkers: tools in personalized oncology. Mol Diagn Ther (2014) 18:273-84. doi:10.1007/s40291-013-0077-9
5. Buschmann D, Haberberger A, Kirchner B, Spornraft M, Riedmaier I, Schelling G, et al. Toward reliable biomarker signatures in the age of liquid biopsies-how to standardize the small RNA-Seq workflow. Nucleic Acids Res (2016) 44:5995-6018. doi:10.1093/nar/gkw545
6. Ballman KV. Biomarker: predictive or prognostic? J Clin Oncol (2015) 33:3968-71. doi:10.1200/JCO.2015.63.3651
7. Ramilo O, Allman W, Chung W, Mejias A, Ardura M, Glaser C, et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood (2007) 109:2066-77. doi:10.1182/blood-2006-02-002477
8. Mejias A, Ramilo O. Transcriptional profiling in infectious diseases: ready for prime time? J Infect (2014) 68(Suppl 1):S94-9. doi:10.1016/j.jinf.2013.09.018
9. Weiner J, Kaufmann SH. High-throughput and computational approaches for diagnostic and prognostic host tuberculosis biomarkers. Int J Infect Dis (2017) (in press). doi:10.1016/j.ijid.2016.10.017
10. Mohr S, Liew CC. The peripheral-blood transcriptome: new insights into disease and risk assessment. Trends Mol Med (2007) 13:422-32. doi:10.1016/j.molmed.2007.08.003
11. Blankley S, Berry MP, Graham CM, Bloom CI, Lipman M, O'Garra A. The application of transcriptional blood signatures to enhance our understanding of the host response to infection: the example of tuberculosis. Philos Trans R Soc Lond B Biol Sci (2014) 369:20130427. doi:10.1098/rstb.2013.0427
12. Chaussabel D. Assessment of immune status using blood transcriptomics and potential implications for global health. Semin Immunol (2015) 27:58-66. doi:10.1016/j.smim.2015.03.002
13. Kaufmann SH, Fortune S, Pepponi I, Ruhwald M, Schrager LK, OttenhoffTH. TB biomarkers, TB correlates and human challenge models: new tools for improving assessment of new TB vaccines. Tuberculosis (Edinb) (2016) 99(Suppl 1):S8-11. doi:10.1016/j.tube.2016.05.010
14. Vordermeier HM, Jones GJ, Buddle BM, Hewinson RG, Villarreal-Ramos B. Bovine tuberculosis in cattle: vaccines, diva tests, and host biomarker discovery. Annu Rev Anim Biosci (2016) 4:87-109. doi:10.1146/annurev-animal-021815-111311
15. Esterhuyse MM, Weiner J III, Caron E, Loxton AG, Iannaccone M, Wagman C, et al. Epigenetics and proteomics join transcriptomics in the quest for tuberculosis biomarkers. MBio (2015) 6:e1187-1115. doi:10.1128/mBio.01187-15
16. Wallis RS, Peppard T. Early biomarkers and regulatory innovation in multidrug-resistant tuberculosis. Clin Infect Dis (2015) 61(Suppl 3):S160-3. doi:10.1093/cid/civ612
17. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell (1993) 75:843-54. doi:10.1016/0092-8674(93)90529-Y
18. Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell (1993) 75:855-62. doi:10.1016/0092-8674(93)90530-4
19. Kozomara A, Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res (2014) 42:D68-73. doi:10.1093/nar/gkt1181
20. Wheeler BM, Heimberg AM, Moy VN, Sperling EA, Holstein TW, Heber S, et al. The deep evolution of metazoan microRNAs. Evol Dev (2009) 11:50-68. doi:10.1111/j.1525-142X.2008.00302.x
21. Berezikov E. Evolution of microRNA diversity and regulation in animals. Nat Rev Genet (2011) 12:846-60. doi:10.1038/nrg3079
22. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol (2010) 10:111-22. doi:10.1038/nri2708
23. O'Neill LA, Sheedy FJ, McCoy CE. microRNAs: the fine-tuners of toll-like receptor signalling. Nat Rev Immunol (2011) 11:163-75. doi:10.1038/nri2957
24. Shenoy A, Blelloch RH. Regulation of microRNA function in somatic stem cell proliferation and differentiation. Nat Rev Mol Cell Biol (2014) 15:565-76. doi:10.1038/nrm3854
25. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, et al. microRNA genes are transcribed by RNA polymerase II. EMBO J (2004) 23:4051-60. doi:10.1038/sj.emboj.7600385
26. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature (2003) 425:415-9. doi:10.1038/nature01957
27. Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev (2004) 18:3016-27. doi:10.1101/gad.1262504
28. Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U. Nuclear export of microRNA precursors. Science (2004) 303:95-8. doi:10.1126/science.1090599
29. Zhang HD, Kolb FA, Brondani V, Billy E, Filipowicz W. Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP. EMBO J (2002) 21:5875-85. doi:10.1093/emboj/cdf582
30. Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K, et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature (2005) 436:740-4. doi:10.1038/nature03868
31. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell (2003) 115:787-98. doi:10.1016/s0092-8674(03)01018-3
32. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD. Asymmetry in the assembly of the RNAi enzyme complex. Cell (2003) 115:199-208. doi:10.1016/s0092-8674(03)00759-1
33. Kim Y, Yeo J, Lee JH, Cho J, Seo D, Kim JS, et al. Deletion of human tarbp2 reveals cellular microRNA targets and cell-cycle function of TRBP. Cell Rep (2014) 9:1061-74. doi:10.1016/j.celrep.2014.09.039
34. Wilson RC, Tambe A, Kidwell MA, Noland CL, Schneider CP, Doudna JA. Dicer-TRBP complex formation ensures accurate mammalian microRNA biogenesis. Mol Cell (2015) 57:397-407. doi:10.1016/j.molcel.2014.11.030
35. Morin RD, O'Connor MD, Griffith M, Kuchenbauer F, Delaney A, Prabhu AL, et al. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res (2008) 18:610-21. doi:10.1101/gr.7179508
36. Neilsen CT, Goodall GJ, Bracken CP. IsomiRs-the overlooked repertoire in the dynamic microRNAome. Trends Genet (2012) 28:544-9. doi:10.1016/j.tig.2012.07.005
37. Guo L, Chen F. A challenge for miRNA: multiple isomiRs in miRNAomics. Gene (2014) 544:1-7. doi:10.1016/j.gene.2014.04.039
38. Okamura K, Hagen JW, Duan H, Tyler DM, Lai EC. The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell (2007) 130:89-100. doi:10.1016/j.cell.2007.06.028
39. Ruby JG, Jan CH, Bartel DP. Intronic microRNA precursors that bypass Drosha processing. Nature (2007) 448:83-6. doi:10.1038/nature05983
40. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2002) 99:15524-9. doi:10.1073/pnas.242606799
41. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res (2004) 64:3753-6. doi:10.1158/0008-5472.CAN-04-0637
42. Bianchi F, Nicassio F, Marzi M, Belloni E, Dall'Olio V, Bernard L, et al. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med (2011) 3:495-503. doi:10.1002/emmm.201100154
43. Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, et al. microRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A (2011) 108:3713-8. doi:10.1073/pnas.1100048108
44. Ciesla M, Skrzypek K, Kozakowska M, Loboda A, Jozkowicz A, Dulak J. microRNAs as biomarkers of disease onset. Anal Bioanal Chem (2011) 401:2051-61. doi:10.1007/s00216-011-5001-8
45. Tan X, Qin W, Zhang L, Hang J, Li B, Zhang C, et al. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis. Clin Cancer Res (2011) 17:6802-11. doi:10.1158/1078-0432.CCR-11-0419
46. Gasparini P, Cascione L, Landi L, Carasi S, Lovat F, Tibaldi C, et al. microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers. Proc Natl Acad Sci U S A (2015) 112:14924-9. doi:10.1073/pnas.1520329112
47. Du F, Yuan P, Zhao ZT, Yang Z, Wang T, Zhao JD, et al. A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment. Sci Rep (2016) 6:33825. doi:10.1038/srep33825
48. Kurozumi S, Yamaguchi Y, Kurosumi M, Ohira M, Matsumoto H, Horiguchi J. Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes. J Hum Genet (2017) 62:15-24. doi:10.1038/jhg.2016.89
49. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. microRNAs: new regulators of immune cell development and function. Nat Immunol (2008) 9:839-45. doi:10.1038/ni.f.209
50. Pauley KM, Chan EK. microRNAs and their emerging roles in immunology. Ann N Y Acad Sci (2008) 1143:226-39. doi:10.1196/annals.1443.009
51. Lu LF, Liston A. microRNA in the immune system, microRNA as an immune system. Immunology (2009) 127:291-8. doi:10.1111/j.1365-2567.2009.03092.x
52. O'Connell RM, Rao DS, Baltimore D. microRNA regulation of inflammatory responses. Annu Rev Immunol (2012) 30:295-312. doi:10.1146/annurev-immunol-020711-075013
53. Chen CZ, Schaffert S, Fragoso R, Loh C. Regulation of immune responses and tolerance: the microRNA perspective. Immunol Rev (2013) 253:112-28. doi:10.1111/imr.12060
54. Zhu S, Pan W, Qian Y. microRNA in immunity and autoimmunity. J Mol Med (Berl) (2013) 91:1039-50. doi:10.1007/s00109-013-1043-z
55. Yang L, Seki E. Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms. Front Physiol (2012) 3:138. doi:10.3389/fphys.2012.00138
56. He X, Jing Z, Cheng G. microRNAs: new regulators of toll-like receptor signalling pathways. Biomed Res Int (2014) 2014:945169. doi:10.1155/2014/945169
57. Liston A, Linterman M, Lu LF. microRNA in the adaptive immune system, in sickness and in health. J Clin Immunol (2010) 30:339-46. doi:10.1007/s10875-010-9378-5
58. Dooley J, Linterman MA, Liston A. microRNA regulation of T-cell development. Immunol Rev (2013) 253:53-64. doi:10.1111/imr.12049
59. Jeker LT, Bluestone JA. microRNA regulation of T-cell differentiation and function. Immunol Rev (2013) 253:65-81. doi:10.1111/imr.12061
60. Podshivalova K, Salomon DR. microRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development. Crit Rev Immunol (2013) 33:435-76. doi:10.1615/CritRevImmunol.2013006858
61. Tang X, Tang R, Xu Y, Wang Q, Hou Y, Shen S, et al. microRNA networks in regulatory T cells. J Physiol Biochem (2014) 70:869-75. doi:10.1007/s13105-014-0348-x
62. Amado T, Schmolka N, Metwally H, Silva-Santos B, Gomes AQ. Cross-regulation between cytokine and microRNA pathways in T cells. Eur J Immunol (2015) 45:1584-95. doi:10.1002/eji.201545487
63. Clare S, John V, Walker AW, Hill JL, Abreu-Goodger C, Hale C, et al. Enhanced susceptibility to Citrobacter rodentium infection in microRNA-155-deficient mice. Infect Immun (2013) 81:723-32. doi:10.1128/IAI.00969-12
64. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, et al. Requirement of bic/microRNA-155 for normal immune function. Science (2007) 316:608-11. doi:10.1126/science.1139253
65. Lind EF, Elford AR, Ohashi PS. micro-RNA 155 is required for optimal CD8+ T cell responses to acute viral and intracellular bacterial challenges. J Immunol (2013) 190:1210-6. doi:10.4049/jimmunol.1202700
66. Bala S, Tilahun Y, Taha O, Alao H, Kodys K, Catalano D, et al. Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection. J Transl Med (2012) 10:151. doi:10.1186/1479-5876-10-151
67. Jablonski KA, Gaudet AD, Amici SA, Popovich PG, Guerau-de-Arellano M. Control of the inflammatory macrophage transcriptional signature by miR-155. PLoS One (2016) 11:e0159724. doi:10.1371/journal.pone.0159724
68. Staedel C, Darfeuille F. microRNAs and bacterial infection. Cell Microbiol (2013) 15:1496-507. doi:10.1111/cmi.12159
69. Furci L, Schena E, Miotto P, Cirillo DM. Alteration of human macrophages microRNA expression profile upon infection with Mycobacterium tuberculosis. Int J Mycobacteriol (2013) 2:128-34. doi:10.1016/j.ijmyco.2013.04.006
70. Vegh P, Magee DA, Nalpas NC, Bryan K, McCabe MS, Browne JA, et al. microRNA profiling of the bovine alveolar macrophage response to Mycobacterium bovis infection suggests pathogen survival is enhanced by microRNA regulation of endocytosis and lysosome trafficking. Tuberculosis (2015) 95:60-7. doi:10.1016/j.tube.2014.10.011
71. Eulalio A, Schulte L, Vogel J. The mammalian microRNA response to bacterial infections. RNA Biol (2012) 9:742-50. doi:10.4161/rna.20018
72. Bettencourt P, Pires D, Anes E. Immunomodulating microRNAs of mycobacterial infections. Tuberculosis (Edinb) (2016) 97:1-7. doi:10.1016/j.tube.2015.12.004
73. Wang Y, Cai Y. A survey on database resources for microRNA-disease relationships. Brief Funct Genomics (2017) (in press). doi:10.1093/bfgp/elw015
74. Contreras J, Rao DS. microRNAs in inflammation and immune responses. Leukemia (2012) 26:404-13. doi:10.1038/leu.2011.356
75. Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol (2014) 14:195-208. doi:10.1038/nri3622
76. Fernandez-Messina L, Gutierrez-Vazquez C, Rivas-Garcia E, Sanchez-Madrid F, de la Fuente H. Immunomodulatory role of microRNAs transferred by extracellular vesicles. Biol Cell (2015) 107:61-77. doi:10.1111/boc.201400081
77. de Candia P, De Rosa V, Casiraghi M, Matarese G. Extracellular RNAs: a secret arm of immune system regulation. J Biol Chem (2016) 291:7221-8. doi:10.1074/jbc. R115.708842
78. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, et al. The microRNA spectrum in 12 body fluids. Clin Chem (2010) 56:1733-41. doi:10.1373/clinchem.2010.147405
79. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A (2011) 108:5003-8. doi:10.1073/pnas.1019055108
80. Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res (2011) 39:7223-33. doi:10.1093/nar/gkr254
81. Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z, et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell (2010) 39:133-44. doi:10.1016/j.molcel.2010.06.010
82. Wang K, Zhang S, Weber J, Baxter D, Galas DJ. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res (2010) 38:7248-59. doi:10.1093/nar/gkq601
83. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. microRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol (2011) 8:467-77. doi:10.1038/nrclinonc.2011.76
84. Mandel P, Metais P. Les acides nucléiques du plasma sanguin chez l'homme [The nucleic acids from blood plasma in humans]. C R Seances Soc Biol Fil (1948) 142:241-3.
85. Swarup V, Rajeswari MR. Circulating (cell-free) nucleic acids-a promising, non-invasive tool for early detection of several human diseases. FEBS Lett (2007) 581:795-9. doi:10.1016/j.febslet.2007.01.051
86. Chim SS, Shing TK, Hung EC, Leung TY, Lau TK, Chiu RW, et al. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem (2008) 54:482-90. doi:10.1373/clinchem.2007.097972
87. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol (2008) 141:672-5. doi:10.1111/j.1365-2141.2008.07077.x
88. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 105:10513-8. doi:10.1073/pnas.0804549105
89. Schwarzenbach H, Nishida N, Calin GA, Pantel K. Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol (2014) 11:145-56. doi:10.1038/nrclinonc.2014.5
90. Ono S, Lam S, Nagahara M, Hoon DS. Circulating microRNA biomarkers as liquid biopsy for cancer patients: pros and cons of current assays. J Clin Med (2015) 4:1890-907. doi:10.3390/jcm4101890
91. Wang J, Chen J, Sen S. microRNA as biomarkers and diagnostics. J Cell Physiol (2016) 231:25-30. doi:10.1002/jcp.25056
92. Diamandis EP. The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem? BMC Med (2012) 10:87. doi:10.1186/1741-7015-10-87
93. Koberle V, Pleli T, Schmithals C, Augusto Alonso E, Haupenthal J, Bonig H, et al. Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers. PLoS One (2013) 8:e75184. doi:10.1371/journal.pone.0075184
94. Shaughnessy RG, Farrell D, Riepema K, Bakker D, Gordon SV. Analysis of biobanked serum from a Mycobacterium avium subsp paratuberculosis bovine infection model confirms the remarkable stability of circulating miRNA profiles and defines a bovine serum miRNA repertoire. PLoS One (2015) 10:e0145089. doi:10.1371/journal.pone.0145089
95. Unger L, Fouche N, Leeb T, Gerber V, Pacholewska A. Optimized methods for extracting circulating small RNAs from long-term stored equine samples. Acta Vet Scand (2016) 58:44. doi:10.1186/s13028-016-0224-5
96. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem (2011) 57:833-40. doi:10.1373/clinchem.2010.157198
97. Wang K, Yuan Y, Cho JH, McClarty S, Baxter D, Galas DJ. Comparing the microRNA spectrum between serum and plasma. PLoS One (2012) 7:e41561. doi:10.1371/journal.pone.0041561
98. Blondal T, Jensby Nielsen S, Baker A, Andreasen D, Mouritzen P, Wrang Teilum M, et al. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods (2013) 59:S1-6. doi:10.1016/j.ymeth.2012.09.015
99. Binderup HG, Houlind K, Madsen JS, Brasen CL. Pre-storage centrifugation conditions have significant impact on measured microRNA levels in biobanked EDTA plasma samples. Biochem Biophys Rep (2016) 7:195-200. doi:10.1016/j.bbrep.2016.06.005
100. Kim DJ, Linnstaedt S, Palma J, Park JC, Ntrivalas E, Kwak-Kim JY, et al. Plasma components affect accuracy of circulating cancer-related microRNA quantitation. J Mol Diagn (2012) 14:71-80. doi:10.1016/j.jmoldx.2011.09.002
101. Li S, Chen H, Song J, Lee C, Geng Q. Avoiding heparin inhibition in circulating microRNAs amplification. Int J Cardiol (2016) 207:92-3. doi:10.1016/j.ijcard.2016.01.129
102. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, Miyaji MM, et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) (2012) 5:492-7. doi:10.1158/1940-6207.CAPR-11-0370
103. Kim YK, Yeo J, Kim B, Ha M, Kim VN. Short structured RNAs with low GC content are selectively lost during extraction from a small number of cells. Mol Cell (2012) 46:893-5. doi:10.1016/j.molcel.2012.05.036
104. Pritchard CC, Cheng HH, Tewari M. microRNA profiling: approaches and considerations. Nat Rev Genet (2012) 13:358-69. doi:10.1038/nrg3198
105. Di Leva G, Croce CM. miRNA profiling of cancer. Curr Opin Genet Dev (2013) 23:3-11. doi:10.1016/j.gde.2013.01.004
106. Baker M. microRNA profiling: separating signal from noise. Nat Methods (2010) 7:687-92. doi:10.1038/nmeth0910-687
107. Kolbert CP, Feddersen RM, Rakhshan F, Grill DE, Simon G, Middha S, et al. Multi-platform analysis of microRNA expression measurements in RNA from fresh frozen and FFPE tissues. PLoS One (2013) 8:e52517. doi:10.1371/journal.pone.0052517
108. Tian T, Wang J, Zhou X. A review: microRNA detection methods. Org Biomol Chem (2015) 13:2226-38. doi:10.1039/c4ob02104e
109. Fiedler SD, Carletti MZ, Christenson LK. Quantitative RT-PCR methods for mature microRNA expression analysis. Methods Mol Biol (2010) 630:49-64. doi:10.1007/978-1-60761-629-0_4
110. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res (2005) 33:e179. doi:10.1093/nar/gni178
111. Koshkin AA, Singh SK, Nielsen P, Rajwanshi VK, Kumar R, Meldgaard M, et al. LNA (locked nucleic acids): synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation, and unprecedented nucleic acid recognition. Tetrahedron (1998) 54:3607-30. doi:10.1016/S0040-4020(98)00094-5
112. Kok MG, Halliani A, Moerland PD, Meijers JC, Creemers EE, Pinto-Sietsma SJ. Normalization panels for the reliable quantification of circulating microRNAs by RT-qPCR. FASEB J (2015) 29:3853-62. doi:10.1096/fj.15-271312
113. Schlosser K, McIntyre LA, White RJ, Stewart DJ. Customized internal reference controls for improved assessment of circulating microRNAs in disease. PLoS One (2015) 10:e0127443. doi:10.1371/journal.pone.0127443
114. Marabita F, de Candia P, Torri A, Tegner J, Abrignani S, Rossi RL. Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR. Brief Bioinform (2016) 17:204-12. doi:10.1093/bib/bbv056
115. Wu D, Hu Y, Tong S, Williams BR, Smyth GK, Gantier MP. The use of miRNA microarrays for the analysis of cancer samples with global miRNA decrease. RNA (2013) 19:876-88. doi:10.1261/rna.035055.112
116. Nalpas NC, Park SD, Magee DA, Taraktsoglou M, Browne JA, Conlon KM, et al. Whole-transcriptome, high-throughput RNA sequence analysis of the bovine macrophage response to Mycobacterium bovis infection in vitro. BMC Genomics (2013) 14:230. doi:10.1186/1471-2164-14-230
117. McLoughlin KE, Nalpas NC, Rue-Albrecht K, Browne JA, Magee DA, Killick KE, et al. RNA-seq transcriptional profiling of peripheral blood leukocytes from cattle infected with Mycobacterium bovis. Front Immunol (2014) 5:396. doi:10.3389/fimmu.2014.00396
118. Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL, et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol (2008) 26:317-25. doi:10.1038/nbt1385
119. Wang RY, Weng KF, Huang YC, Chen CJ. Elevated expression of circulating miR876-5p is a specific response to severe EV71 infections. Sci Rep (2016) 6:24149. doi:10.1038/srep24149
120. Yamamoto M, Singh A, Ruan J, Gauvreau GM, O'Byrne PM, Carlsten CR, et al. Decreased miR-192 expression in peripheral blood of asthmatic individuals undergoing an allergen inhalation challenge. BMC Genomics (2012) 13:655. doi:10.1186/1471-2164-13-655
121. Vikram A, Kim YR, Kumar S, Li Q, Kassan M, Jacobs JS, et al. Vascular microRNA-204 is remotely governed by the microbiome and impairs endothelium-dependent vasorelaxation by downregulating Sirtuin1. Nat Commun (2016) 7:12565. doi:10.1038/ncomms12565
122. Keller A, Leidinger P, Bauer A, Elsharawy A, Haas J, Backes C, et al. Toward the blood-borne miRNome of human diseases. Nat Methods (2011) 8:841-3. doi:10.1038/nmeth.1682
123. Li N, You X, Chen T, Mackowiak SD, Friedlander MR, Weigt M, et al. Global profiling of miRNAs and the hairpin precursors: insights into miRNA processing and novel miRNA discovery. Nucleic Acids Res (2013) 41:3619-34. doi:10.1093/nar/gkt072
124. Siddle KJ, Tailleux L, Deschamps M, Loh YH, Deluen C, Gicquel B, et al. Bacterial infection drives the expression dynamics of microRNAs and their isomiRs. PLoS Genet (2015) 11:e1005064. doi:10.1371/journal.pgen.1005064
125. Huang HC, Niu Y, Qin LX. Differential expression analysis for RNA-seq: an overview of statistical methods and computational software. Cancer Inform (2015) 14:57-67. doi:10.4137/CIN.S21631
126. Ziemann M, Kaspi A, El-Osta A. Evaluation of microRNA alignment techniques. RNA (2016) 22:1120-38. doi:10.1261/rna.055509.115
127. Raabe CA, Tang TH, Brosius J, Rozhdestvensky TS. Biases in small RNA deep sequencing data. Nucleic Acids Res (2014) 42:1414-26. doi:10.1093/nar/gkt1021
128. Baroin-Tourancheau A, Benigni X, Doubi-Kadmiri S, Taouis M, Amar L. Lessons from microRNA sequencing using Illumina technology. Adv Biosci Biotechnol (2016) 07:319-28. doi:10.4236/abb.2016.77030
129. Graybill RM, Bailey RC. Emerging biosensing approaches for microRNA analysis. Anal Chem (2016) 88:431-50. doi:10.1021/acs.analchem.5b04679
130. Benz F, Roderburg C, Vargas Cardenas D, Vucur M, Gautheron J, Koch A, et al. U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis. Exp Mol Med (2013) 45:e42. doi:10.1038/emm.2013.81
131. D'Haene B, Mestdagh P, Hellemans J, Vandesompele J. miRNA expression profiling: from reference genes to global mean normalization. Methods Mol Biol (2012) 822:261-72. doi:10.1007/978-1-61779-427-8_18
132. Reid G, Kirschner MB, van Zandwijk N. Circulating microRNAs: association with disease and potential use as biomarkers. Crit Rev Oncol Hematol (2011) 80:193-208. doi:10.1016/j.critrevonc.2010.11.004
133. Tang G, Shen X, Lv K, Wu Y, Bi J, Shen Q. Different normalization strategies might cause inconsistent variation in circulating microRNAs in patients with hepatocellular carcinoma. Med Sci Monit (2015) 21:617-24. doi:10.12659/MSM.891028
134. Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, Speleman F, et al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol (2009) 10:R64. doi:10.1186/gb-2009-10-6-r64
135. Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol (2010) 11:R25. doi:10.1186/gb-2010-11-3-r25
136. Bullard JH, Purdom E, Hansen KD, Dudoit S. Evaluation of statistical methods for normalization and differential expression in mRNA-seq experiments. BMC Bioinformatics (2010) 11:94. doi:10.1186/1471-2105-11-94
137. Tam S, Tsao MS, McPherson JD. Optimization of miRNA-seq data preprocessing. Brief Bioinform (2015) 16:950-63. doi:10.1093/bib/bbv019
138. Garmire LX, Subramaniam S. Evaluation of normalization methods in mammalian microRNA-Seq data. RNA (2012) 18:1279-88. doi:10.1261/rna.030916.111
139. Cleveland WS, Devlin SJ. Locally weighted regression: an approach to regression analysis by local fitting. J Am Stat Assoc (1988) 83:596. doi:10.1080/01621459.1988.10478639
140. Jain N, Thatte J, Braciale T, Ley K, O'Connell M, Lee JK. Local-pooled-error test for identifying differentially expressed genes with a small number of replicated microarrays. Bioinformatics (2003) 19:1945-51. doi:10.1093/bioinformatics/btg264
141. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics (2003) 19:185-93. doi:10.1093/bioinformatics/19.2.185
142. Dillies MA, Rau A, Aubert J, Hennequet-Antier C, Jeanmougin M, Servant N, et al. A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis. Brief Bioinform (2013) 14:671-83. doi:10.1093/bib/bbs046
143. Zhou X, Oshlack A, Robinson MD. miRNA-Seq normalization comparisons need improvement. RNA (2013) 19:733-4. doi:10.1261/rna.037895.112
144. World Health Organization. Global Tuberculosis Report 2015. Geneva: World Health Organization (2015).
145. Leylabadlo HE, Kafil HS, YousefiM, Aghazadeh M, Asgharzadeh M. Pulmonary tuberculosis diagnosis: where we are? Tuberc Respir Dis (Seoul) (2016) 79:134-42. doi:10.4046/trd.2016.79.3.134
146. Pai M, Schito M. Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects. J Infect Dis (2015) 211(Suppl 2):S21-8. doi:10.1093/infdis/jiu803
147. Fu Y, Yi Z, Wu X, Li J, Xu F. Circulating microRNAs in patients with active pulmonary tuberculosis. J Clin Microbiol (2011) 49:4246-51. doi:10.1128/JCM.05459-11
148. Yi Z, Fu Y, Ji R, Li R, Guan Z. Altered microRNA signatures in sputum of patients with active pulmonary tuberculosis. PLoS One (2012) 7:e43184. doi:10.1371/journal.pone.0043184
149. Qi Y, Cui L, Ge Y, Shi Z, Zhao K, Guo X, et al. Altered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infection. BMC Infect Dis (2012) 12:384. doi:10.1186/1471-2334-12-384
150. Abd-El-Fattah AA, Sadik NA, Shaker OG, Aboulftouh ML. Differential microRNAs expression in serum of patients with lung cancer, pulmonary tuberculosis, and pneumonia. Cell Biochem Biophys (2013) 67:875-84. doi:10.1007/s12013-013-9575-y
151. Zhang X, Guo J, Fan S, Li Y, Wei L, Yang X, et al. Screening and identification of six serum microRNAs as novel potential combination biomarkers for pulmonary tuberculosis diagnosis. PLoS One (2013) 8:e81076. doi:10.1371/journal.pone.0081076
152. Zhang H, Sun Z, Wei W, Liu Z, Fleming J, Zhang S, et al. Identification of serum microRNA biomarkers for tuberculosis using RNA-seq. PLoS One (2014) 9:e88909. doi:10.1371/journal.pone.0088909
153. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol (2008) 9:503-10. doi:10.1038/ni1582
154. Zhang C, Xi X, Wang Q, Jiao J, Zhang L, Zhao H, et al. The association between serum miR-155 and natural killer cells from tuberculosis patients. Int J Clin Exp Med (2015) 8:9168-72.
155. Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol (2008) 8:776-87. doi:10.1038/nri2402
156. Parlato M, Cavaillon JM. Host response biomarkers in the diagnosis of sepsis: a general overview. Methods Mol Biol (2015) 1237:149-211. doi:10.1007/978-1-4939-1776-1_15
157. Benz F, Roy S, Trautwein C, Roderburg C, Luedde T. Circulating microRNAs as biomarkers for sepsis. Int J Mol Sci (2016) 17:E78. doi:10.3390/ijms17010078
158. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, et al. microRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One (2009) 4:e7405. doi:10.1371/journal.pone.0007405
159. Puskarich MA, Nandi U, Shapiro NI, Trzeciak S, Kline JA, Jones AE. Detection of microRNAs in patients with sepsis. J Acute Dis (2015) 4:101-6. doi:10.1016/s2221-6189(15)30017-2
160. Roderburg C, Luedde M, Vargas Cardenas D, Vucur M, Scholten D, Frey N, et al. Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsis. PLoS One (2013) 8:e54612. doi:10.1371/journal.pone.0054612
161. Wang JF, Yu ML, Yu G, Bian JJ, Deng XM, Wan XJ, et al. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun (2010) 394:184-8. doi:10.1016/j.bbrc.2010.02.145
162. Wang L, Wang HC, Chen C, Zeng J, Wang Q, Zheng L, et al. Differential expression of plasma miR-146a in sepsis patients compared with non-sepsis-SIRS patients. Exp Ther Med (2013) 5:1101-4. doi:10.3892/etm.2013.937
163. Benz F, Tacke F, Luedde M, Trautwein C, Luedde T, Koch A, et al. Circulating microRNA-223 serum levels do not predict sepsis or survival in patients with critical illness. Dis Markers (2015) 2015:384208. doi:10.1155/2015/384208
164. Tacke F, Roderburg C, Benz F, Cardenas DV, Luedde M, Hippe HJ, et al. Levels of circulating miR-133a are elevated in sepsis and predict mortality in critically ill patients. Crit Care Med (2014) 42:1096-104. doi:10.1097/CCM.0000000000000131
165. Roderburg C, Benz F, Vargas Cardenas D, Koch A, Janssen J, Vucur M, et al. Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases. Liver Int (2015) 35:1172-84. doi:10.1111/liv.12627
166. Wang H, Meng K, Chen W, Feng D, Jia Y, Xie L. Serum miR-574-5p: a prognostic predictor of sepsis patients. Shock (2012) 37:263-7. doi:10.1097/SHK.0b013e318241baf8
167. Wang H, Zhang P, Chen W, Feng D, Jia Y, Xie L. Serum microRNA signatures identified by Solexa sequencing predict sepsis patients' mortality: a prospective observational study. PLoS One (2012) 7:e38885. doi:10.1371/journal.pone.0038885
168. World Health Organization. Hepatitis B Fact Sheet. (2016). Available from: http://www.who.int/mediacentre/factsheets/fs204/en
169. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine (2012) 30:2212-9. doi:10.1016/j.vaccine.2011.12.116
170. Ji F, Yang B, Peng X, Ding H, You H, Tien P. Circulating microRNAs in hepatitis B virus-infected patients. J Viral Hepat (2011) 18:e242-51. doi:10.1111/j.1365-2893.2011.01443.x
171. Song G, Jia H, Xu H, Liu W, Zhu H, Li S, et al. Studying the association of microRNA-210 level with chronic hepatitis B progression. J Viral Hepat (2014) 21:272-80. doi:10.1111/jvh.12138
172. Wang JY, Mao RC, Zhang YM, Zhang YJ, Liu HY, Qin YL, et al. Serum microRNA-124 is a novel biomarker for liver necroinflammation in patients with chronic hepatitis B virus infection. J Viral Hepat (2015) 22:128-36. doi:10.1111/jvh.12284
173. Zhang Q, Xu M, Qu Y, Li Z, Zhang Q, Cai X, et al. Analysis of the differential expression of circulating microRNAs during the progression of hepatic fibrosis in patients with chronic hepatitis B virus infection. Mol Med Rep (2015) 12:5647-54. doi:10.3892/mmr.2015.4221
174. Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z, et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol (2011) 29:4781-8. doi:10.1200/JCO.2011.38.2697
175. Winther TN, Jacobsen KS, Mirza AH, Heiberg IL, Bang-Berthelsen CH, Pociot F, et al. Circulating microRNAs in plasma of hepatitis B e antigen positive children reveal liver-specific target genes. Int J Hepatol (2014) 2014:791045. doi:10.1155/2014/791045
176. Qi P, Cheng SQ, Wang H, Li N, Chen YF, Gao CF. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One (2011) 6:e28486. doi:10.1371/journal.pone.0028486
177. Tan Y, Ge G, Pan T, Wen D, Chen L, Yu X, et al. A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus. PLoS One (2014) 9:e107986. doi:10.1371/journal.pone.0107986
178. Sohn W, Kim J, Kang SH, Yang SR, Cho JY, Cho HC, et al. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma. Exp Mol Med (2015) 47:e184. doi:10.1038/emm.2015.68
179. Yu F, Lu Z, Chen B, Dong P, Zheng J. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma. Diagn Pathol (2015) 10:129. doi:10.1186/s13000-015-0369-y
180. Li L, Guo Z, Wang J, Mao Y, Gao Q. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening. Dig Dis Sci (2012) 57:2910-6. doi:10.1007/s10620-012-2317-y
181. Zhang Y, Jia Y, Zheng R, Guo Y, Wang Y, Guo H, et al. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem (2010) 56:1830-8. doi:10.1373/clinchem.2010.147850
182. Zhang X, Zhang Z, Dai F, Shi B, Chen L, Zhang X, et al. Comparison of circulating, hepatocyte specific messenger RNA and microRNA as biomarkers for chronic hepatitis B and C. PLoS One (2014) 9:e92112. doi:10.1371/journal.pone.0092112
183. Xu J, Wu C, Che X, Wang L, Yu D, Zhang T, et al. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog (2011) 50:136-42. doi:10.1002/mc.20712
184. Zhang H, Li QY, Guo ZZ, Guan Y, Du J, Lu YY, et al. Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis B. World J Gastroenterol (2012) 18:5188-96. doi:10.3748/wjg.v18.i37.5188
185. Arataki K, Hayes CN, Akamatsu S, Akiyama R, Abe H, Tsuge M, et al. Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B. J Med Virol (2013) 85:789-98. doi:10.1002/jmv.23540
186. Waidmann O, Bihrer V, Pleli T, Farnik H, Berger A, Zeuzem S, et al. Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection. J Viral Hepat (2012) 19:e58-65. doi:10.1111/j.1365-2893.2011.01536.x
187. Winther TN, Bang-Berthelsen CH, Heiberg IL, Pociot F, Hogh B. Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B. PLoS One (2013) 8:e58236. doi:10.1371/journal.pone.0058236
188. Winther TN, Heiberg IL, Bang-Berthelsen CH, Pociot F, Hogh B. Hepatitis B surface antigen quantity positively correlates with plasma levels of microRNAs differentially expressed in immunological phases of chronic hepatitis B in children. PLoS One (2013) 8:e80384. doi:10.1371/journal.pone.0080384
189. Chen Y, Li L, Zhou Z, Wang N, Zhang CY, Zen K. A pilot study of serum microRNA signatures as a novel biomarker for occult hepatitis B virus infection. Med Microbiol Immunol (2012) 201:389-95. doi:10.1007/s00430-011-0223-0
190. Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, Zhang JF, et al. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res (2010) 70:9798-807. doi:10.1158/0008-5472.CAN-10-1001
191. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science (2005) 309:1577-81. doi:10.1126/science.1113329
192. Bihrer V, Friedrich-Rust M, Kronenberger B, Forestier N, Haupenthal J, Shi Y, et al. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. Am J Gastroenterol (2011) 106:1663-9. doi:10.1038/ajg.2011.161
193. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One (2011) 6:e23937. doi:10.1371/journal.pone.0023937
194. van der Meer AJ, Farid WR, Sonneveld MJ, de Ruiter PE, Boonstra A, van Vuuren AJ, et al. Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122. J Viral Hepat (2013) 20:158-66. doi:10.1111/jvh.12001
195. Wang JH, Jiang D, Rao HY, Zhao JM, Wang Y, Wei L. Absolute quantification of serum microRNA-122 and its correlation with liver inflammation grade and serum alanine aminotransferase in chronic hepatitis C patients. Int J Infect Dis (2015) 30:52-6. doi:10.1016/j.ijid.2014.09.020
196. Zhang S, Ouyang X, Jiang X, Gu D, Lin Y, Kong SK, et al. Dysregulated serum microRNA expression profile and potential biomarkers in hepatitis C virus-infected patients. Int J Med Sci (2015) 12:590-8. doi:10.7150/ijms.11525
197. Trebicka J, Anadol E, Elfimova N, Strack I, Roggendorf M, Viazov S, et al. Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis. J Hepatol (2013) 58:234-9. doi:10.1016/j.jhep.2012.10.015
198. Su TH, Liu CH, Liu CJ, Chen CL, Ting TT, Tseng TC, et al. Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C. Proc Natl Acad Sci U S A (2013) 110:7844-9. doi:10.1073/pnas.1306138110
199. Estrabaud E, Lapalus M, Broet P, Appourchaux K, De Muynck S, Lada O, et al. Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C. J Virol (2014) 88:6394-402. doi:10.1128/JVI.00016-14
200. El-Diwany R, Wasilewski LN, Witwer KW, Bailey JR, Page K, Ray SC, et al. Acute hepatitis C virus infection induces consistent changes in circulating microRNAs that are associated with nonlytic hepatocyte release. J Virol (2015) 89:9454-64. doi:10.1128/JVI.00955-15
201. Roderburg C, Mollnow T, Bongaerts B, Elfimova N, Vargas Cardenas D, Berger K, et al. Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis. PLoS One (2012) 7:e32999. doi:10.1371/journal.pone.0032999
202. Shrivastava S, Petrone J, Steele R, Lauer GM, Di Bisceglie AM, Ray RB. Up-regulation of circulating miR-20a is correlated with hepatitis C virus-mediated liver disease progression. Hepatology (2013) 58:863-71. doi:10.1002/hep.26296
203. Shwetha S, Gouthamchandra K, Chandra M, Ravishankar B, Khaja MN, Das S. Circulating miRNA profile in HCV infected serum: novel insight into pathogenesis. Sci Rep (2013) 3:1555. doi:10.1038/srep01555
204. El-Abd NE, Fawzy NA, El-Sheikh SM, Soliman ME. Circulating miRNA-122, miRNA-199a, and miRNA-16 as biomarkers for early detection of hepatocellular carcinoma in Egyptian patients with chronic hepatitis C virus infection. Mol Diagn Ther (2015) 19:213-20. doi:10.1007/s40291-015-0148-1
205. Qu KZ, Zhang K, Li H, Afdhal NH, Albitar M. Circulating microRNAs as biomarkers for hepatocellular carcinoma. J Clin Gastroenterol (2011) 45:355-60. doi:10.1097/MCG.0b013e3181f18ac2
206. Bihrer V, Waidmann O, Friedrich-Rust M, Forestier N, Susser S, Haupenthal J, et al. Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma. PLoS One (2011) 6:e26971. doi:10.1371/journal.pone.0026971
207. Tomimaru Y, Eguchi H, Nagano H, Wada H, Kobayashi S, Marubashi S, et al. Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. J Hepatol (2012) 56:167-75. doi:10.1016/j.jhep.2011.04.026
208. Ge Y, Zhao K, Qi Y, Min X, Shi Z, Qi X, et al. Serum microRNA expression profile as a biomarker for the diagnosis of pertussis. Mol Biol Rep (2013) 40:1325-32. doi:10.1007/s11033-012-2176-9
209. Sanmarti M, Ibanez L, Huertas S, Badenes D, Dalmau D, Slevin M, et al. HIV-associated neurocognitive disorders. J Mol Psychiatry (2014) 2:2. doi:10.1186/2049-9256-2-2
210. Zayyad Z, Spudich S. Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND). Curr HIV/AIDS Rep (2015) 12:16-24. doi:10.1007/s11904-014-0255-3
211. Kadri F, LaPlante A, De Luca M, Doyle L, Velasco-Gonzalez C, Patterson JR, et al. Defining plasma microRNAs associated with cognitive impairment in HIV-infected patients. J Cell Physiol (2016) 231:829-36. doi:10.1002/jcp.25131
212. Witwer KW, Sarbanes SL, Liu J, Clements JE. A plasma microRNA signature of acute lentiviral infection: biomarkers of central nervous system disease. AIDS (2011) 25:2057-67. doi:10.1097/QAD.0b013e32834b95bf
213. Pacifici M, Delbue S, Ferrante P, Jeansonne D, Kadri F, Nelson S, et al. Cerebrospinal fluid miRNA profile in HIV-encephalitis. J Cell Physiol (2013) 228:1070-5. doi:10.1002/jcp.24254
214. Ding NZ, Wang XM, Sun SW, Song Q, Li SN, He CQ. Appearance of mosaic enterovirus 71 in the 2008 outbreak of China. Virus Res (2009) 145:157-61. doi:10.1016/j.virusres.2009.06.006
215. Cui L, Qi Y, Li H, Ge Y, Zhao K, Qi X, et al. Serum microRNA expression profile distinguishes enterovirus 71 and coxsackievirus 16 infections in patients with hand-foot-and-mouth disease. PLoS One (2011) 6:e27071. doi:10.1371/journal.pone.0027071
216. Jia HL, He CH, Wang ZY, Xu YF, Yin GQ, Mao LJ, et al. microRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease. BMC Infect Dis (2014) 14:506. doi:10.1186/1471-2334-14-506
217. Qi Y, Zhu Z, Shi Z, Ge Y, Zhao K, Zhou M, et al. Dysregulated microRNA expression in serum of non-vaccinated children with varicella. Viruses (2014) 6:1823-36. doi:10.3390/v6041823
218. Tambyah PA, Sepramaniam S, Mohamed Ali J, Chai SC, Swaminathan P, Armugam A, et al. microRNAs in circulation are altered in response to influenza A virus infection in humans. PLoS One (2013) 8:e76811. doi:10.1371/journal.pone.0076811
219. Moran J, Ramirez-Martinez G, Jimenez-Alvarez L, Cruz A, Perez-Patrigeon S, Hidalgo A, et al. Circulating levels of miR-150 are associated with poorer outcomes of A/H1N1 infection. Exp Mol Pathol (2015) 99:253-61. doi:10.1016/j.yexmp.2015.07.001
220. Zhu Z, Qi Y, Ge A, Zhu Y, Xu K, Ji H, et al. Comprehensive characterization of serum microRNA profile in response to the emerging avian influenza A (H7N9) virus infection in humans. Viruses (2014) 6:1525-39. doi:10.3390/v6041525
221. Fabres-Klein MH, Aguilar AP, Silva MP, Silva DM, Ribon AO. Moving towards the immunodiagnosis of staphylococcal intramammary infections. Eur J Clin Microbiol Infect Dis (2014) 33:2095-104. doi:10.1007/s10096-014-2181-0
222. Sun J, Aswath K, Schroeder SG, Lippolis JD, Reinhardt TA, Sonstegard TS. microRNA expression profiles of bovine milk exosomes in response to Staphylococcus aureus infection. BMC Genomics (2015) 16:806. doi:10.1186/s12864-015-2044-9
223. Farrell D, Shaughnessy RG, Britton L, MacHugh DE, Markey B, Gordon SV. The identification of circulating miRNA in bovine serum and their potential as novel biomarkers of early Mycobacterium avium subsp paratuberculosis infection. PLoS One (2015) 10:e0134310. doi:10.1371/journal.pone.0134310
224. Casas E, Cai G, Kuehn LA, Register KB, McDaneld TG, Neill JD. Association of microRNAs with antibody response to Mycoplasma bovis in beef cattle. PLoS One (2016) 11:e0161651. doi:10.1371/journal.pone.0161651